2025
|
Invention
|
Certain chemical entities, compositions and methods.
Chemical entities that modulate PI3 kinase ... |
2019
|
Invention
|
Certain chemical entities, compositions and methods. Chemical entities that modulate PI3 kinase a... |
2017
|
Invention
|
Heterocyclic compounds and uses thereof.
Heterocyclic entities that modulate PI3 kinase activity... |
|
Invention
|
Treatment regimens using multiple pharmaceutical agents.
The present invention provides for meth... |
2016
|
Invention
|
Heterocyclic kinase inhibitors. Provided herein are compounds of formula (I-A), (I-B), (I-C), or ... |
|
Invention
|
Combination of mtor inhibitors and pi3-kinase inhibitors, and uses thereof.
The present inventio... |
2015
|
Invention
|
Substituted isoquinolin-1(2h)-one compounds, compositions, and methods thereof. Chemical entities... |
|
Invention
|
Kinase inhibitors and methods of use. The present invention provides chemical entities or compoun... |
|
Invention
|
Benzothiazole kinase inhibitors and methods of use. The present invention provides chemical entit... |
2014
|
Invention
|
Combination of kinase inhibitors and uses thereof.
The present invention provides for a method f... |
2013
|
Invention
|
Chemical entities and therapeutic uses thereof.
Certain chemical entities that modulate PI3 kina... |
|
Invention
|
Treatment of polycystic disease.
The present invention provides methods of treating polycystic d... |
|
Invention
|
Substituted isoquinolin-1(2h)-one compounds, compositions, and methods thereof. Substituted isoqu... |
2012
|
Invention
|
Enhanced treatment regimens using mtor inhibitors. The present invention provides for methods and... |
|
Invention
|
Enhanced treatment regimens using mtor inhibitors. Methods and pharmaceutical compositions compri... |
|
Invention
|
Combination of kinase inhibitors and uses thereof. The present invention provides for a method fo... |
|
Invention
|
Kinase inhibitor polymorphs. Polymorphs of chemical compounds that modulate kinase activity, incl... |
|
Invention
|
Treatment regimens using multiple pharmaceutical agents. The present invention provides for metho... |
|
Invention
|
Kinase inhibitor polymorphs. Polymorphs, hydrates, and solvates of chemical compounds that modula... |
|
Invention
|
Treatment of polycystic disease. The present invention provides methods of treating polycystic di... |
|
Invention
|
Reactive mtor and pi3 kinase inhibitors and uses thereof. The present invention provides for a co... |
|
Invention
|
Heterocyclic compounds and uses thereof. Heterocyclic entities that modulate PI3 kinase activity,... |
|
Invention
|
Combination of mtor inhibitors and p13-kinase inhibitors, and uses thereof. The present invention... |